Comparable stake leader
ASTRAZENECA PLC
SEC ownership of Cellectis S.A.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001627281.
Disclosed value leader
ASTRAZENECA PLC
Comparable rows
34/34
Latest evidence
31 Mar 2026
- Public ticker
- CLLS on Nasdaq
- Parsed ownership sources
- 13D/G and 13F
- Largest SEC-reported holder
- ASTRAZENECA PLC
- Latest 13D/G holder
- ASTRAZENECA PLC
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0001627281
- Issuer location
- Paris, Lle De France
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Cellectis S.A. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ASTRAZENECA PLC
Disclosed value leader
ASTRAZENECA PLC
Comparable rows
34/34
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 44%
13D/G row: ASTRAZENECA PLC
Showing 1-8 of 34 holder rows.
Quick read
ASTRAZENECA PLC leads the comparable SEC ownership view at 44%.
34 of 34 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ASTRAZENECA PLC's linked filing trail.
Comparable ownership
Top 5
ASTRAZENECA PLC
44%
Bpifrance Participations SA
11%
B Group, Inc.
3.4%
UBS AM, a distinct business unit ...
3.3%
Long Focus Capital Management, LLC
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 34 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ASTRAZENECA PLC |
13D/G
|
44%
|
$66,440,000
44,000,000 shares
|
$0 | 23 Jan 2025 |
| Bpifrance Participations SA |
13D/G
Caisse des Depots
|
11%
|
$33,176,247
10,599,440 shares
|
+$960,243 | 03 Dec 2025 |
| B Group, Inc. |
13F
Company
|
3.4%
|
$10,402,358
3,281,501 shares
|
— | 31 Mar 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
Company
|
3.3%
|
$10,076,226
3,178,620 shares
|
— | 31 Mar 2026 |
| Long Focus Capital Management, LLC |
13F
Company
|
2.9%
|
$8,698,791
2,744,098 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
0.36%
|
$1,082,627
341,523 shares
|
— | 31 Mar 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
Company
|
0.24%
|
$719,000
226,875 shares
|
— | 31 Mar 2026 |
| MORGAN STANLEY |
13F
Company
|
0.09%
|
$275,080
86,776 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 06 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Recent insider transactions for Cellectis S.A.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.